COMP <GO>
SRTS vs XTNT // 10Y YIELD & FRED MACRO BETA
Sensus Healthcare Inc. (NASDAQ) VS. Xtant Medical Holdings Inc. (NYSE) • 15-METRIC TALLY: SRTS 3
— XTNT 7
■ METRIC PARITY
LAST: $2.77 (-1.77%) • MKT CAP: $45.6M
macro-sensitivity
—
LAST: $0.29 (+1.54%) • MKT CAP: $40.7M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRTS VS. XTNT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SRTS | XTNT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 43.20% | 62.90% | -19.70 | XTNT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.30% | 12.80% | -44.10 | XTNT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 3.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.73% | 24.95% | -24.22 | XTNT | /fcf-yield <GO> |
| Operating Margin | -37.50% | 5.40% | -42.90 | XTNT | /operating-margins <GO> |
| Net Profit Margin | -28.10% | 0.00% | -28.10 | XTNT | /net-margins <GO> |
| Revenue Growth (YoY) | -34.30% | 14.20% | -48.50 | XTNT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.50 | 0.20 | +6.30 | SRTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | XTNT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.3 | 34.9 | +4.34 | SRTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.6M | $40.7M | $4.9M | SRTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SRTS REV | XTNT REV | SRTS GROSS % | XTNT GROSS % | SRTS FCF | XTNT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $27.5M | $133.9M | 43.2% | 62.9% | $332.0K | $10.2M |
| FY 2024 | $41.8M | $117.3M | 58.4% | 58.2% | -$1.1M | -$16.0M |
| FY 2023 | $24.4M | $91.3M | — | — | -$2.1M | -$9.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRTS // BETA —
XTNT // BETA —